tiprankstipranks
Trending News
More News >
Sumitomo Dainippon Pharma Co Ltd (DNPUF)
OTHER OTC:DNPUF
US Market
Advertisement

Sumitomo Dainippon Pharma Co (DNPUF) Ratios

Compare
8 Followers

Sumitomo Dainippon Pharma Co Ratios

DNPUF's free cash flow for Q4 2024 was ¥0.58. For the 2024 fiscal year, DNPUF's free cash flow was decreased by ¥ and operating cash flow was ¥-2.72. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 21
Liquidity Ratios
Current Ratio
1.05 0.52 0.52 1.79 1.79
Quick Ratio
0.66 0.30 0.30 1.44 1.44
Cash Ratio
0.10 0.06 0.06 0.73 0.73
Solvency Ratio
0.09 -0.37 -0.37 0.15 0.15
Operating Cash Flow Ratio
0.07 -0.47 -0.47 0.11 0.11
Short-Term Operating Cash Flow Coverage
0.36 -0.85 -0.85 1.25 1.25
Net Current Asset Value
¥ -319.96B¥ -481.80B¥ -481.80B¥ -134.92B¥ -134.92B
Leverage Ratios
Debt-to-Assets Ratio
0.41 0.46 0.46 0.21 0.21
Debt-to-Equity Ratio
1.80 2.68 2.68 0.44 0.44
Debt-to-Capital Ratio
0.64 0.73 0.73 0.31 0.31
Long-Term Debt-to-Capital Ratio
0.60 0.46 0.46 0.29 0.29
Financial Leverage Ratio
4.38 5.81 5.81 2.15 2.15
Debt Service Coverage Ratio
0.64 -0.94 -0.94 2.91 2.91
Interest Coverage Ratio
1.13 -82.81 -82.81 19.75 19.75
Debt to Market Cap
<0.01 2.67 2.60 0.56 0.56
Interest Debt Per Share
832.78 1.07K 1.07K 684.88 684.88
Net Debt to EBITDA
7.09 -1.39 -1.39 0.53 0.53
Profitability Margins
Gross Profit Margin
61.53%59.76%59.76%71.94%71.94%
EBIT Margin
3.57%-101.36%-101.36%15.36%15.36%
EBITDA Margin
9.98%-89.35%-89.35%22.21%22.21%
Operating Profit Margin
7.22%-112.60%-112.60%10.76%10.76%
Pretax Profit Margin
4.42%-102.72%-102.72%14.81%14.81%
Net Profit Margin
5.93%-100.13%-100.13%10.07%10.07%
Continuous Operations Profit Margin
5.93%-100.12%-100.12%7.25%7.25%
Net Income Per EBT
134.20%97.48%97.48%68.00%68.00%
EBT Per EBIT
61.17%91.23%91.23%137.73%137.73%
Return on Assets (ROA)
3.18%-34.71%-34.71%4.31%4.31%
Return on Equity (ROE)
15.48%-201.82%-201.82%9.28%9.28%
Return on Capital Employed (ROCE)
5.73%-90.35%-90.35%5.85%5.85%
Return on Invested Capital (ROIC)
7.04%-50.95%-50.95%2.78%2.78%
Return on Tangible Assets
6.34%-61.51%-61.51%7.90%7.90%
Earnings Yield
0.03%-201.08%-195.27%11.75%11.75%
Efficiency Ratios
Receivables Turnover
5.33 3.88 3.88 3.70 3.70
Payables Turnover
3.98 1.87 1.87 7.00 7.00
Inventory Turnover
1.63 1.10 1.10 1.59 1.59
Fixed Asset Turnover
8.55 5.43 5.43 8.74 8.74
Asset Turnover
0.54 0.35 0.35 0.43 0.43
Working Capital Turnover Ratio
-5.21 -2.66 -2.66 2.78 2.78
Cash Conversion Cycle
200.94 231.36 231.36 276.54 276.54
Days of Sales Outstanding
68.49 94.02 94.02 98.68 98.68
Days of Inventory Outstanding
224.14 332.63 332.63 230.02 230.02
Days of Payables Outstanding
91.69 195.28 195.28 52.16 52.16
Operating Cycle
292.63 426.64 426.64 328.70 328.70
Cash Flow Ratios
Operating Cash Flow Per Share
41.53 -608.85 -608.85 78.63 78.63
Free Cash Flow Per Share
20.14 -648.45 -648.45 44.66 44.66
CapEx Per Share
21.39 39.59 39.59 33.96 33.96
Free Cash Flow to Operating Cash Flow
0.48 1.07 1.07 0.57 0.57
Dividend Paid and CapEx Coverage Ratio
1.94 -13.06 -13.06 1.27 1.27
Capital Expenditure Coverage Ratio
1.94 -15.38 -15.38 2.32 2.32
Operating Cash Flow Coverage Ratio
0.05 -0.58 -0.58 0.12 0.12
Operating Cash Flow to Sales Ratio
0.04 -0.77 -0.77 0.06 0.06
Free Cash Flow Yield
<0.01%-164.47%-159.72%3.70%3.70%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
3.68K -0.50 -0.51 8.51 8.51
Price-to-Sales (P/S) Ratio
217.94 0.50 0.51 0.86 0.86
Price-to-Book (P/B) Ratio
512.87 1.00 1.03 0.79 0.79
Price-to-Free Cash Flow (P/FCF) Ratio
10.86K -0.61 -0.63 27.05 27.05
Price-to-Operating Cash Flow Ratio
5.27K -0.65 -0.67 15.36 15.36
Price-to-Earnings Growth (PEG) Ratio
32.43 >-0.01 >-0.01 24.57 24.57
Price-to-Fair Value
512.87 1.00 1.03 0.79 0.79
Enterprise Value Multiple
2.19K -1.94 -1.96 4.39 4.39
Enterprise Value
86.96T 546.48B 551.14B 545.99B 545.99B
EV to EBITDA
2.19K -1.94 -1.96 4.39 4.39
EV to Sales
218.04 1.74 1.75 0.97 0.97
EV to Free Cash Flow
10.87K -2.12 -2.14 30.77 30.77
EV to Operating Cash Flow
5.27K -2.26 -2.28 17.48 17.48
Tangible Book Value Per Share
-504.51 -602.33 -602.33 200.69 200.69
Shareholders’ Equity Per Share
426.59 392.82 392.82 1.53K 1.53K
Tax and Other Ratios
Effective Tax Rate
-0.34 0.03 0.03 0.51 0.51
Revenue Per Share
1.00K 791.76 791.76 1.41K 1.41K
Net Income Per Share
59.49 -792.79 -792.79 141.99 141.99
Tax Burden
1.34 0.97 0.97 0.68 0.68
Interest Burden
1.24 1.01 1.01 0.96 0.96
Research & Development to Revenue
0.13 0.36 0.36 0.17 0.17
SG&A to Revenue
0.00 1.37 1.13 0.44 0.44
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.70 0.77 0.77 0.77 0.77
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis